Quotient case study

Why Quotient Limited (QTNT) jumped 29% on 09/12/17? Quotient Limited (QTNT) jumped 29% as a result of Bullish news signal: Quotient Limited , a commercial-stage diagnostics company, today reported progress on performance evaluation studies for MosaiQ. “Our latest performance evaluation results represent a key final step prior to commencing our verification and validation studies, allowing us [...]

By | September 12th, 2017|case studies, Uncategorized|Comments Off on Quotient case study

Idera Pharmaceuticals case study

Why Idera Pharmaceuticals, Inc. (IDRA) jumped 18% on 09/11/17? Idera Pharmaceuticals, Inc. (IDRA) jumped 18% as a result of Bullish news signal: Idera Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with rare cancers and rare diseases, today announced final results from the dose-selection phase of an ongoing Phase [...]

By | September 11th, 2017|case studies, Uncategorized|Comments Off on Idera Pharmaceuticals case study

Marinus Pharmaceuticals case study

Why Marinus Pharmaceuticals, Inc. (MRNS) 49% on 09/11/17? Marinus Pharmaceuticals, Inc. (MRNS) jumped 49% as a result of Bullish news signal: Marinus Pharmaceuticals Inc. saw its shares make a huge gain to kick off the week after the firm announced top-line results from its mid-stage study in patients with  CDKL5 disorder. Essentially, the Phase 2 [...]

By | September 11th, 2017|case studies, Uncategorized|Comments Off on Marinus Pharmaceuticals case study

TEVA case study

Why Teva Pharmaceutical Industries Limited (TEVA) 18% on 09/11/17? Teva Pharmaceutical Industries Limited (TEVA) jumped 18% as a result of Bullish news signal: The world's biggest generic drug maker Monday named Kare Schultz as president and CEO, ending months of speculation about who would replace former head Erez Vigodman, who left the company in February [...]

By | September 11th, 2017|Uncategorized|Comments Off on TEVA case study

A look ahead Sep 11-15

A look ahead to the major events, economic releases and company news expected next week Sep 11-15. In the week ahead, we will have seen how the force and impact of Hurricane Irma will have struck the continental U.S. Current models show Miami to be the most at-risk, though Governor Rick Scott said all Floridians ought to evacuate, [...]

By | September 10th, 2017|Uncategorized|Comments Off on A look ahead Sep 11-15

Fred’s case study

Why Fred's, Inc. (FRED) 5% on 09/08/17? Fred's, Inc. (FRED) jumped 5% as a result of Bullish news signal: Fred’s Inc. today reported financial results for the second quarter and six months ended July 29, 2017. For the second quarter ended July 29, 2017, Fred’s recorded a net loss of approximately $29.5 million or $0.78 per share, which included the [...]

By | September 8th, 2017|case studies, Uncategorized|Comments Off on Fred’s case study

Kura Oncology case study

Why Kura Oncology, Inc. (KURA) 90% on 09/08/17? Kura Oncology, Inc. (KURA) jumped 90% as a result of Bullish news signal: Shares of Kura Oncology Inc. rocketed 90% on Friday after the biopharmaceutical company announced positive results from a phase 2 study of its cancer treatment. The company said late Thursday that its lead product candidate, tipifarnib, [...]

By | September 8th, 2017|case studies, Uncategorized|Comments Off on Kura Oncology case study

Conn’s case study

Why Conn's, Inc. (CONN) 12.5% on 09/07/17? Conn's, Inc. (CONN) jumped 12.5% as a result of Bullish news signal: Conn's, Inc, a specialty retailer of furniture and mattresses, home appliances, consumer electronics and home office products, and provider of consumer credit, today announced its financial results for the second quarter ended July 31, 2017. Net income [...]

By | September 7th, 2017|case studies, Uncategorized|Comments Off on Conn’s case study

Bristol-Myers Squibb case study

Why Bristol-Myers Squibb Company (BMY) 4% on 09/07/17? Bristol-Myers Squibb Company (BMY) jumped 4% as a result of Bullish news signal: Bristol-Myers Squibb Co said on Thursday the success of its combination therapy to improve overall survival in kidney cancer patients helped it end the trial early, despite having reported mixed results on other main [...]

By | September 7th, 2017|case studies, Uncategorized|Comments Off on Bristol-Myers Squibb case study

GoPro case study

Why GoPro, Inc. (GPRO) 16% on 09/07/17? GoPro, Inc. (GPRO) jumped 16% as a result of Bullish news signal: hares of GoPro Inc. soared 19% in active morning trade, putting it on track for seven-month closing high, after the company surprised Wall Street analysts by saying it expected to report an adjusted profit for its third quarter. The company [...]

By | September 7th, 2017|case studies, Uncategorized|Comments Off on GoPro case study